Identification of vulnerabilities for pharmacological inhibition of PIP4K2s in Acute Myeloid Leukemia (2023)
- Authors:
- USP affiliated authors: REGO, EDUARDO MAGALHÃES - FM ; MACHADO NETO, JOÃO AGOSTINHO - ICB ; LIMA, KELI CRISTINA DE - FM ; CARVALHO, MARIA FERNANDA LOPES - ICB ; MARTINS, DIEGO ANTONIO PEREIRA - FMRP ; NASCIMENTO, MARIANE CRISTINA DO - FM ; NOGUEIRA, FREDERICO LISBOA - FM
- Unidades: FM; ICB; FMRP
- DOI: 10.1182/blood-2023-189998
- Subjects: FARMACOLOGIA; HEMATOLOGIA; LEUCEMIA MIELOIDE AGUDA; QUIMIOTERAPIA COMBINADA; CÉLULAS CULTIVADAS DE TUMOR; PROLIFERAÇÃO CELULAR; NEOPLASIAS POR TIPO HISTOLÓGICO; ANTINEOPLÁSICOS; PROTEÍNAS; CÉLULAS MIELOIDES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher: American Society of Hematology
- Publisher place: Washington, DC
- Date published: 2023
- Source:
- Conference titles: 65th ASH Annual Meeting Abstracts
- Status:
- Nenhuma versão em acesso aberto identificada
-
ABNT
LIMA, Keli et al. Identification of vulnerabilities for pharmacological inhibition of PIP4K2s in Acute Myeloid Leukemia. Blood, v. 142, n. Supl. 1, p. 5774, 2023Tradução . . Disponível em: https://doi.org/10.1182/blood-2023-189998. Acesso em: 01 abr. 2026. -
APA
Lima, K., Carvalho, M. F. L., Martins, D. A. P., Nascimento, M. C. do, Nogueira, F. L., Medeiros, R. de C. C., et al. (2023). Identification of vulnerabilities for pharmacological inhibition of PIP4K2s in Acute Myeloid Leukemia. Blood, 142( Supl. 1), 5774. doi:10.1182/blood-2023-189998 -
NLM
Lima K, Carvalho MFL, Martins DAP, Nascimento MC do, Nogueira FL, Medeiros R de CC, Schuringa JJ, Rego EM, Machado Neto JA. Identification of vulnerabilities for pharmacological inhibition of PIP4K2s in Acute Myeloid Leukemia [Internet]. Blood. 2023 ; 142( Supl. 1): 5774.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1182/blood-2023-189998 -
Vancouver
Lima K, Carvalho MFL, Martins DAP, Nascimento MC do, Nogueira FL, Medeiros R de CC, Schuringa JJ, Rego EM, Machado Neto JA. Identification of vulnerabilities for pharmacological inhibition of PIP4K2s in Acute Myeloid Leukemia [Internet]. Blood. 2023 ; 142( Supl. 1): 5774.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1182/blood-2023-189998 - Pharmacological inhibition of PIP4K2 potentiates venetoclax-induced apoptosis in Acute Myeloid Leukemia
- All-trans retinoic acid potentiates cell death induced by quizartinib in acute myeloid leukemia with FLT3-ITD mutations
- Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia
- Acute myeloid leukemia-derived bone marrow mesenchymal cells exhibit improved support for leukemic cell proliferation
- Data mining in acute myeloid leukemia: identification of disease biomarkers, prognostic factors, novel targets, and potential drugs
- Cephalochromin-induced mitochondrial damage overcomes venetoclax-resistance in acute Myeloid Leukemia Models
- Chromomycin A2 exhibits antileukemic effects by coordinated disruption of survival pathways
- Comprehensive analysis of the HCK gene in myeloid neoplasms: insights into biological functions, prognosis, and response to antineoplastic agents
- Synthesis and evaluation of 2-substituted quinazolin-4(3H)-ones as potential antileukemic agents
- In Silico, in vitro, and in vivo studies of a 2-substituted quinazolin-4(3H)-one in T-cell acute lymphoblastic leukemia
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
